ARTICLE | Company News
AtheroGenics endocrine, cardiovascular news
October 13, 2008 7:00 AM UTC
AtheroGenics filed for Chapter 11 bankruptcy and hired Merriman Curhan Ford to assist with the sale of the company or its assets. The biotech said the filing was necessary due to its "substantial debt...